Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Nam Nguyen

Research Fellow in Health Economics

Dr Nam Nguyen has been a researcher at the Nuffield Department of Primary Care Health Sciences since February 2025. He previously worked at the Health Economics Research Centre (HERC) within the Nuffield Department of Population Health. His current research focuses on using large healthcare databases to investigate antibiotic prescribing in primary care and inform antibiotic stewardship interventions. He is also interested in applying new methods to enhance the use of big data, such as instrumental variable approaches to provide unbiased estimates of the causal effects of antibiotic prescribing. His work draws on large observational datasets from both high-income settings (e.g., the Clinical Practice Research Datalink – CPRD) and low-income settings (e.g., the IQVIA Medical Data Index (MDI) for Pakistan, Egypt, and Indonesia) to inform localised guidelines and antibiotic use targets globally.

 

Prior to joining HERC, Nam was based at the Oxford University Clinical Research Unit (OUCRU) in Hanoi, Vietnam, where he completed his PhD focusing on community-level antimicrobial stewardship in low- and middle-income countries. His PhD research examined antibiotic use patterns in Vietnamese primary care settings and the feasibility of implementing point-of-care testing in private pharmacies to reduce over-the-counter antibiotic sales.

 

Earlier in his career, Nam was a university lecturer in pharmacoepidemiology and pharmacoeconomics at the Hanoi University of Pharmacy in Vietnam. He also served as a pharmacovigilance consultant to the Vietnamese Ministry of Health and is a registered pharmacist in Vietnam. He holds a PhD in Life and Health Sciences from the Open University–Oxford University Clinical Research Unit affiliated doctoral programme, and an MSc in Medicines Risk-Benefit Assessment from the European Education and Training Programme in Pharmacovigilance and Pharmacoepidemiology (Eu2P).